3-Nitro Acetophenone

Product Name: 3-nitro acetophenone
CAS-No. 121-89-1
Molecular formula: C8H7NO3
Molecular Weight: 165.15
Appearance: yellow needle crystallization
Purity:> 99%
Product Description: The reduction can bring to the amino group of an amino benzene and medical industries for the production of adrenaline as organic raw materials, etc.

What is PURAC PH90

Product Name: PH90 PURAC
Description: It encourages skin cells to update, and promotes dead and senescent cells, so the skin is soft and smoothly.It is an effective anti-aging agent, and is also a good moisturizer.PURAC PH90 is the natural lactic acid produced by fermentation of sugar and has a slightly acid character and is used in many applications in the pharmaceutical, cosmetic and chemical.

Swertiamarin shop

Product Name: swertiamarin

CAS: 17388-39-5

Molecular weight: 374.34g / mol

Molecular formula: C16H22O10

Description: swertiamarin, a bitter glucoside Secoiridoid is representative of these crude drugs and Swertia herb is generally evaluated by the swertiamarin content. To date, papers, discrimination Swertia bitter herbs other crude drugs, estimating swertiamarin and seasonal fluctuations swertiamarin content described using thin layer chromatography, while others reported swertiamarin quantification documents high performance liquid chromatography (HPLC).

Aluminium tristearate for sale

Product Name: Aluminium tristearate
CAS: 637-12-7
Molecular formula: C54H105AlO6
Formula Weight: 877.39
Description:
Aluminum tristearate is a fine flowing powder without cumbersome fluffy sweet odor. It has mild antiseptic and astringent properties.
It provides smooth creams. It is a normal aluminum soap of stearic acid and place users in many industries. It is by nature insoluble in water and resistant to water.

Fluorite powder price

Product Name: fluorite powder
CAS: 7789-75-5
Molecular Formula: CaF2
Formula Weight: 78.07
Description:
Calcium fluoride has the inorganic compound having the formula CaF2. This ionic compound of calcium and fluorine occurs in nature as the mineral fluorite (also called fluorspar). It is responsible for most of the world fluorine. This insoluble solid adopts a cubic structure, is coordinated with the calcium to eight fluoride anions and each F? Ion is Ca2 + ions.Although four pure material is colorless, colored minerals due to the presence of F centers is often surrounded by depth.

Cefonicid price

Cefonicid was compared for the treatment of severe soft tissue infections with cefazolin. awarded after a prospective randomized protocol twice as many patients developed cefonicid, 38 patients were treated with cefonicid and 19 patients with cefazolin. The doses used were 1.0 g once daily, intramuscularly or intravenously for cefonicid and 0.5 to 1.0 g three times per day intramuscularly or intravenously to cefazolin. Clinical diagnosis included cellulitis (39 patients), abscesses (14), infected ulcers (3) and bursitis (1). bacteriological diagnosis only contain Staphylococcus aureus (8 patients), group A streptococcus only (13) associated with S. aureus and streptococci (8), a viridans streptococci only group (1) and mixed anaerobic (1). Gram-negative bacilli were isolated from 11 patients, all in mixed cultures with Gram-positive species. In two patients, Gram-negative organisms were considered causal agent. All 57 patients responded satisfactorily to treatment. Treatment with other medication has not been interrupted or discontinued due to toxicity. Two cefonicid cefazolin and appear to be effective for the treatment of infections of the skin and soft tissue. Cefonicid has the advantage of once-daily administration.

What is Ceftazidime,and price

Avibactam (formerly NXL104, AVE1330A) is a β-lactamase non-synthetic β-lactam inhibitor that inhibits the activity of Ambler class A and C beta-lactamase enzymes and certain Ambler class D. This review summarizes the available data for ceftazidime published avibactam including the relevant chemistry, mechanisms of action and resistance, microbiology, pharmacokinetics, pharmacodynamics and efficacy and safety data from animal and human studies. Although not a β-lactam, the chemical structure of avibactam resembles parts of the cephem bicyclic ring system has been shown and avibactam covalently attached to ß-lactamases connect. Very little is known about the potential for resistance to avibactam choose. Adding a strong avibactam (4-1024 times the minimum inhibitory concentration reduction [MIC]) improves the activity of ceftazidime against most Enterobacteriaceae species, depending on the presence or absence of the β-lactamase enzyme (s). Against Pseudomonas aeruginosa, adding avibactam improves ceftazidime activity (MIC ~ reduction four times). Limited data suggest that adding avibactam not enhance the activity of ceftazidime against Acinetobacter species or most anaerobic bacteria (exceptions: .. Bacteroides fragilis, Clostridium perfringens, Prevotella spp and Porphyromonas spp). The pharmacokinetics of avibactam follow a two-compartment model and do not seem to be affected by concomitant administration of ceftazidime. The maximum concentration of drug in plasma (C (max)) and the area under the plasma concentration-time curve (AUC) between avibactam increase linearly with doses of 50 mg to 2000 mg. The mean volume of distribution and half-life of 22 L (~ 0.3 L / kg) and ~ 2 hours, changed, are similar to ceftazidime. How avibactam ceftazidime is mainly excreted by the kidneys, and the clearance was correlated with creatinine clearance. The pharmacodynamic data suggest that ceftazidime quickly avibactam bactericidal against Gram-negative β-lactamase producing bacteria which are not inhibited by ceftazidime alone.Clinical studies to date have reported that ceftazidime avibactam is as effective as the standard treatment for carbapenem complicated intra-abdominal infection is and complicated urinary tract infections, including caused by gram-negative resistant cephalosporin isolates the infection. The safety and tolerability of ceftazidime avibactam was reported in three Phase I pharmacokinetic studies and two Phase II clinical trials. Ceftazidime avibactam seems date.In statements reported in healthy volunteers and patients to the hospital to be met with few serious adverse effects associated with drug well tolerated treatment is avibactam the ceftazidime spectrum to expand against ß-lactamase producing Gram-negative bacilli. The exact ceftazidime avibactam roles will be defined by the efficacy and safety data from other clinical trials. possible future roles for ceftazidime avibactam include treatment of suspected or documented infections caused by gram negative bacilli resistant to producing extended-spectrum beta-lactamase carbapenemases (ESBL) Klebsiella pneumoniae (CCP) and / or AmpC ß-lactamases. In addition, ceftazidime avibactam used in combination (with metronidazole) used on suspicion of polymicrobial infections. Finally, the increase of the activity of ceftazidime against P. aeruginosa is avibactam may be beneficial clinical P. aeruginosa infections with suspected or documented in patients.